Риск сердечно-сосудистых осложнений у пациентов с сахарным диабетом находящихся на гемодиализе

1. Пропедевтика внутренних болезней в рисунках, таблицах и схемах: учеб. пособие/ под ред. А. Н. Куликова, С. Н. Шуленина. - М.: ГЭОТАР-Медиа, 2016. - 624 с.
2. Zheng Y., Ley S. H., Hu F. B. Global etiology and epidemiology of type 2 diabetes mellitus and its complications //Nature Reviews Endocrinology. - 2018. - Т. 14. - №. 2. - С. 88.
3. Abubakar I. I., Tillmann T., Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 //Lancet. - 2015. - Т. 385. - №. 9963. - С. 117-171.
4. IDF Diabetes Atlas. — 7-е изд. — Brussels: Belgium: International Diabetes Federation, 2015. — 297 c.
5. Шестакова М. В. и др. Эпидемиология сахарного диабета в Российской Федерации: что изменилось за последнее десятилетие //Терапевтический архив. - 2019. - Т. 91. - №. 10. - С. 4-13.
6. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999 //Diabetic Medicine. - 2006. - Т. 23. - №. 8.
- С. 857-866.
7. Forouhi N. G., Wareham N. J. Epidemiology of diabetes //Medicine. - 2010. - Т. 38. - №. 11. - С. 602-606.
8. Zimmet P. Z. Diabetes and its drivers: the largest epidemic in human history? //Clinical diabetes and endocrinology. - 2017. - Т. 3. - №. 1. - С. 1.
9. Зайчик А. Ш., Чурилов Л. П. Основы патохимии //ЭЛБИ-СПб, Санкт-Петербург. - 2000. С. 301-318.
10. Nolan C. J., Damm P., Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management //The Lancet. - 2011. - Т. 378. - №. 9786. - С. 169-181.
11. Балаболкин М. И. Сахарный диабет //М.: Медицина. - 1994. - Т. 1.
- С. 383.
12. Kaur N., Kishore L., Singh R. Diabetic autonomic neuropathy: pathogenesis to pharmacological management //J Diabetes Metab. - 2014. - Т. 5. - №. 7. - С. 1-8.
13. Haas A. V., McDonnell M. E. Pathogenesis of cardiovascular disease in diabetes //Endocrinology and Metabolism Clinics. - 2018. - Т. 47. - №. 1.
- С. 51-63.
14. Ram J. L., Conn P. M. (ed.). Conn's Handbook of Models for Human Aging. - 2-е изд. - Academic Press, 2018. - 1218 с.
15. Jia G., DeMarco V. G., Sowers J. R. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy //Nature Reviews Endocrinology. - 2016. - Т. 12. - №. 3. - С. 144.
16. Шанин В.Ю. Патофизиология критических состояний. — 2-е изд.
- СПб.: Элби, 2018. — 440 с.
17. Rubler S. et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis //American Journal of Cardiology. - 1972. - Т. 30. - №. 6. - С. 595-602.
18. Ghosh J., Kapur R. Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia //Experimental hematology. - 2017. - Т. 50. - С. 13-21.
19. Шпаков А. О., Деркач К. В. Гормональные системы мозга и сахарный диабет 2-го типа //Спб.: Изд-во Политехн. ун-та. - 2015. - 252 с.
20. Beckman J. A., Creager M. A., Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management //Jama. - 2002. - Т. 287. - №. 19. - С. 2570-2581.
21. De Vriese A. S. et al. Endothelial dysfunction in diabetes //British journal of pharmacology. - 2000. - Т. 130. - №. 5. - С. 963-974.
22. Milstien S., Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function //Biochemical and biophysical research communications. - 1999. - Т. 263. - №. 3. - С. 681¬684.
23. Hennes M. M. I. et al. Insulin-resistant lipolysis in abdominally obese hypertensive individuals: role of the renin-angiotensin system //Hypertension.
- 1996. - Т. 28. - №. 1. - С. 120-126.
24. Li Y., Woo V., Bose R. Platelet hyperactivity and abnormal Ca2+ homeostasis in diabetes mellitus //American Journal of Physiology-Heart and Circulatory Physiology. - 2001. - Т. 280. - №. 4. - С. H1480-H1489.
25. Inoguchi T. et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD (P) H oxidase in cultured vascular cells //Diabetes. - 2000.
- Т. 49. - №. 11. - С. 1939-1945.
26. Zou M., Yesilkaya A., Ullrich V. Peroxynitrite inactivates prostacyclin synthase by heme-thiolate-catalyzed tyrosine nitration //Drug metabolism reviews. - 1999. - Т. 31. - №. 2. - С. 343-349.
27. Quehenberger P. et al. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells //Diabetes. - 2000. - Т. 49. - №. 9. - С. 1561-1570.
28. Christlieb A. R. et al. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects //Diabetes. - 1976. - Т. 25. - №. 4. - С. 268-274.
29. Tesfamariam B. et al. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta //The Journal of clinical investigation. - 1990. - Т. 85. - №. 3. - С. 929-932.
30. Schmidt A. M., Stern D. Atherosclerosis and diabetes: the RAGE connection //Current atherosclerosis reports. - 2000. - Т. 2. - №. 5. - С. 430-436.
31. Dichtl W. et al. Very low-density lipoprotein activates nuclear factor- кВ in endothelial cells //Circulation research. - 1999. - Т. 84. - №. 9. - С. 1085-1094.
32. Rosen P. et al. The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society //Diabetes/metabolism research and reviews. - 2001. - Т. 17. - №. 3. - С. 189-212.
33. Assert R. et al. Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro //Diabetologia. - 2001.
- Т. 44. - №. 2. - С. 188-195.
34. Vinik A. I. et al. Platelet dysfunction in type 2 diabetes //Diabetes care.
- 2001. - Т. 24. - №. 8. - С. 1476-1485.
35. Carr M. E. Diabetes mellitus: a hypercoagulable state //Journal of Diabetes and its Complications. - 2001. - Т. 15. - №. 1. - С. 44-54.
36. Ceriello A. et al. Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans //Diabetologia. - 1990. - Т. 33. - №. 3. - С. 163-167.
37. Nordt T. K., Bode C. Impaired endogenous fibrinolysis in diabetes mellitus: mechanisms and therapeutic approaches //Seminars in thrombosis and hemostasis. - 2000. - Т. 26. - №. 05. - С. 495-502.
38. Караваев П. Г., Веклич А. С., Козиолова Н. А. Диабетическая кардиомиопатия: особенности сердечно-сосудистого ремоделирования //Российский кардиологический журнал. - 2019. - №. 11. - С. 42-47
39. Lorenzo-Almoros A. et al. Diagnostic approaches for diabetic cardiomyopathy //Cardiovascular diabetology. - 2017. - Т. 16. - №. 1. - С. 28.
40. Suran D., Sinkovic A., Naji F. Tissue Doppler imaging is a sensitive echocardiographic technique to detect subclinical systolic and diastolic dysfunction of both ventricles in type 1 diabetes mellitus //BMC cardiovascular disorders. - 2016. - Т. 16. - №. 1. - С. 72.
41. Marcinkiewicz A., Ostrowski S., Drzewoski J. Can the onset of heart failure be delayed by treating diabetic cardiomyopathy? //Diabetology & metabolic syndrome. - 2017. - Т. 9. - №. 1. - С. 21.
42. Brunvand L. et al. Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study //BMC cardiovascular disorders. - 2016. - Т. 16. - №. 1. - С. 103.
43. Jia G., Whaley-Connell A., Sowers J. R. Diabetic cardiomyopathy: a hyperglycaemia-and insulin-resistance-induced heart disease //Diabetologia.
- 2018. - Т. 61. - №. 1. - С. 21-28.
44. Stratton I. M. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study //Bmj. - 2000. - Т. 321. - №. 7258. - С. 405-412.
45. Jia G. et al. Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females //Hypertension. - 2015.
- Т. 66. - №. 6. - С. 1159-1167.
46. Kim J. et al. Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation //American Journal of Physiology-Endocrinology and Metabolism. - 2012. - Т. 302. - №. 2. - С. E201-E208.
47. Van Heerebeek L. et al. d. van, V, GJ Stienen, GJ Laarman, HW Niessen, WJ Paulus, Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension //Circulation. - 2008. - Т. 117. - С. 43-51.
48. Lazo M. et al. Soluble receptor for advanced glycation end products and the risk for incident heart failure: the Atherosclerosis Risk in Communities Study //American heart journal. - 2015. - Т. 170. - №. 5. - С. 961-967.
49. Ma H. et al. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic
cardiomyopathy //Journal of cellular and molecular medicine. - 2009. - Т. 13.
- №. 8b. - С. 1751-1764.
50. Lee T. W. et al. PPARs modulate cardiac metabolism and mitochondrial function in diabetes //Journal of biomedical science. - 2017. - Т. 24. - №. 1. - С. 5.
51. Miller J. A. et al. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes //Clinical Science. - 1996.
- Т. 90. - №. 3. - С. 189-195.
52. Miller J. A. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus //Journal of the American Society of Nephrology. - 1999. - Т. 10. - №. 8. - С. 1778-1785.
53. Shen J. Z., Young M. J. Corticosteroids, heart failure, and hypertension: a role for immune cells? //Endocrinology. - 2012. - Т. 153. - №. 12. - С. 5692-5700.
54. Ritz, Eberhard, et al. "End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions." American journal of kidney diseases 34.5 (1999): 795-808.
55. Soldatos G., Cooper M. E. Diabetic nephropathy: important pathophysiologic mechanisms //Diabetes research and clinical practice. - 2008. - Т. 82. - С. S75-S79.
56. Parving H. H. Diabetic nephropathy: prevention and treatment //Kidney international. - 2001. - Т. 60. - №. 5. - С. 2041-2055.
57. Remuzzi G., Schieppati A., Ruggenenti P. Nephropathy in patients with type 2 diabetes //New England Journal of Medicine. - 2002. - Т. 346. - №. 15. - С. 1145-1151.
58. Rudofsky G. et al. A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes //Experimental and clinical endocrinology & diabetes. - 2004. - Т. 112. - №. 03. - С. 135-141.
59. Susztak K. et al. Genomic strategies for diabetic nephropathy //Journal of the American Society of Nephrology. - 2003. - Т. 14. - №. suppl 3. - С. S271-S278.
60. Couser W. G. et al. Revisions to instructions to JASN authors regarding articles reporting studies using DNA arrays, DNA polymorphisms, and randomized controlled clinical trials. - 2003.
61. Bowden D. W. et al. A genome scan for diabetic nephropathy in African Americans //Kidney international. - 2004. - Т. 66. - №. 4. - С. 1517-1526.
62. Wolf G., Butzmann U., Wenzel U. O. The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology //Nephron physiology. - 2003. - Т. 93. - №. 1. - С. p3-p13.
63. Anderson S., Rennke H. G., Brenner B. M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat //The Journal of clinical investigation. - 1986. - Т. 77. - №. 6. - С. 1993-2000.
64. Chen S., Wolf G., Ziyadeh F. N. The renin-angiotensin system in diabetic nephropathy //Contributions to nephrology. - 2001. - Т. 135. - С. 212-221.
65. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology //European journal of clinical investigation. - 2004. - Т. 34. - №. 12. - С. 785-796.
66. Thomson S. C., Vallon V., Blantz R. C. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration //American Journal of Physiology-Renal Physiology. - 2004. - Т. 286. - №. 1. - С. F8-F15.
67. Mauer S. M. et al. Structural-functional relationships in diabetic nephropathy //The Journal of clinical investigation. - 1984. - Т. 74. - №. 4. - С. 1143-1155.
68. Wolf G. et al. High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: relationship to hypertrophy //American Journal of Physiology-Renal Physiology. - 1997. - Т. 273. - №. 3. - С. F348- F356.
69. Wolf G. et al. Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats //Diabetologia. - 1999. - Т. 42. - №. 12. - С. 1425-1432.
70. Wolf G. et al. Erk 1, 2 phosphorylates p27 Kip1: Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells //Diabetologia. - 2003. - Т. 46. - №. 8. - С. 1090-1099.
71. Wolf G. et al. High glucose-induced hypertrophy of mesangial cells requires p27Kip1, an inhibitor of cyclin-dependent kinases //The American journal of pathology. - 2001. - Т. 158. - №. 3. - С. 1091-1100.
72. Mason R. M., Wahab N. A. Extracellular matrix metabolism in diabetic nephropathy //Journal of the American Society of Nephrology. - 2003. - Т.
14. - №. 5. - С. 1358-1373.
73. Жункейра, Л. К. Гистология. Атлас / Л. К. Жункейра, Ж. Карнейро.
— Москва: ГЭОТАР-Медиа, 2009. — 576 c.
74. T silibary E. C. Microvascular basement membranes in diabetes mellitus //The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. - 2003. - Т. 200. - №. 4. - С. 537-546.
75. White K. E. et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria //Diabetes. - 2002. - Т. 51. - №. 10. - С. 3083¬3089.
76. Steffes M. W. et al. Glomerular cell number in normal subjects and in type 1 diabetic patients //Kidney international. - 2001. - Т. 59. - №. 6. - С. 2104-2113.
77. Pagtalunan M. E. et al. Podocyte loss and progressive glomerular injury in type II diabetes //The Journal of clinical investigation. - 1997. - Т. 99. - №. 2. - С. 342-348.
78. Dalla Vestra M. et al. Is podocyte injury relevant in diabetic nephropathy?: Studies in patients with type 2 diabetes //Diabetes. - 2003. - Т.
52. - №. 4. - С. 1031-1035.
79. Coimbra T. M. et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes //Kidney international. - 2000. - Т.
57. - №. 1. - С. 167-182.
80. Heilig C. W. et al. Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression //American Journal of Physiology-Renal Physiology. - 2001. - Т. 280. - №. 4. - С. F657-F666.
81. Brownlee M. Biochemistry and molecular cell biology of diabetic complications //Nature. - 2001. - Т. 414. - №. 6865. - С. 813-820.
82. Kang S. W. et al. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen a5 (IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes //Journal of the American Society of Nephrology. - 2003. - Т. 14. - №. 12. - С. 3178-3187.
83. Morrison J. et al. Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response //Physiological genomics. - 2004. - Т. 17. - №. 3. - С. 271-282.
84. Menne J. et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-a—deficient diabetic mice //Diabetes. - 2004. - Т. 53. - №. 8. - С. 2101-2109
85. Haneda M. et al. Overview of glucose signaling in mesangial cells in diabetic nephropathy //Journal of the American Society of Nephrology. - 2003. - Т. 14. - №. 5. - С. 1374-1382.
86. Bernobich E. et al. Antihypertensive treatment and renal damage: amlodipine exerts protective effect through the polyol pathway //Journal of cardiovascular pharmacology. - 2004. - Т. 44. - №. 3. - С. 401-406.
87. Wolf G. Growth factors and the development of diabetic nephropathy //Current diabetes reports. - 2003. - Т. 3. - №. 6. - С. 485-490.
88. Sugimoto H. et al. Increased gene expression of insulin-like growth factor-I receptor in experimental diabetic rat glomeruli //Nephron. - 1996. - Т. 72. - №. 4. - С. 648-653.
89. Poczatek M. H. et al. Glucose stimulation of transforming growth factor-0 bioactivity in mesangial cells is mediated by thrombospondin-1 //The American journal of pathology. - 2000. - Т. 157. - №. 4. - С. 1353-1363.
90. Ziyadeh F. N. et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-0 antibody in db/db diabetic mice //Proceedings of the National Academy of Sciences. - 2000. - Т. 97. - №. 14. - С. 8015-8020.
91. Wang S., Hirschberg R. BMP7 antagonizes TGF-0-dependent fibrogenesis in mesangial cells //American Journal of Physiology-Renal Physiology. - 2003. - Т. 284. - №. 5. - С. F1006-F1013.
92. Onozaki A. et al. Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione //Biochemical and biophysical research communications. - 2004. - Т. 317. - №. 1. - С. 24-29.
93. De Vriese A. S. et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes //Journal of the American Society of Nephrology. - 2001. - Т. 12. - №. 5. - С. 993-1000.
94. Malkina, A. Хроническая болезнь почек / A. Malkina. — Текст :
электронный // Справочник MSD. — URL:
https://www.msdmanuals.com/ru/профессиональный/патология- мочеполовой-системы/хроническая-болезнь-почек/хроническая- болезнь-почек (дата обращения: 19.05.2020).
95. Клинические Практические Рекомендации KDIGO по Диагностике и Лечению Хронической Болезни Почек // Нефрология и диализ. — 2017. — Т. 19. - № 1. — С. 22-206.
96. Matsushita K, van der Velde M, Astor BC, Woodward M, et al Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis //Lancet. - 2010. - Т. 375. - С. 2073-2081.
97. Nitsch D. et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis //Bmj. - 2013. - Т. 346. - С. f324.
98. O'Toole S. M. et al. Managing diabetes in dialysis patients //Postgraduate medical journal. - 2012. - Т. 88. - №. 1037. - С. 160-166.
99. US Renal Data System. USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. - 2013.
100. McIntyre C. W. et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow //Clinical Journal of the American Society of Nephrology. - 2008. - Т.
3. - №. 1. - С. 19-26.
101. Mavrakanas T. A., Charytan D. M. Cardiovascular complications in chronic dialysis patients //Current opinion in nephrology and hypertension. - 2016. - Т. 25. - №. 6. - С. 536 - 551.
102. Lim W. H. et al. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk //Medical Journal of Australia. - 2018. - Т. 209. - №. 10. - С. 440-446.
103. McDonald S. P. Australia and New Zealand dialysis and transplant registry //Kidney international supplements. - 2015. - Т. 5. - №. 1. - С. 39¬44.
104. van Diepen M. et al. Predicting mortality in patients with diabetes starting dialysis //PloS one. - 2014. - Т. 9. - №. 3. - С. - e89744
105. Schroijen M. A. et al. Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition //Diabetologia. - 2013. - Т. 56. - №. 9. - С. 1949-1957.
106. Schroijen M. A. et al. Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition //BMC nephrology. - 2011. - Т. 12. - №. 1. - С. 69.
107. Al-Thani H. et al. Cardiovascular complications in diabetic patients undergoing regular hemodialysis: a 5-year observational study //Angiology. - 2015. - Т. 66. - №. 3. - С. 225-230.
108. Krane V. et al. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis //Clinical Journal of the American Society of Nephrology. - 2009. - Т. 4. - №. 2. - С. 394-400.
109. Jadoul M. et al. Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study //Clinical Journal of the American Society of Nephrology. - 2012. - Т. 7. - №. 5. - С. 765-774.
110. Tancredi M. et al. Excess mortality among persons with type 2 diabetes //New England Journal of Medicine. - 2015. - Т. 373. - №. 18. - С. 1720-1732.

Купить